ARCHIVES

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

This article is from The Cancer Letter archive.

Vol. 35 No. 28 | July 17, 2009

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI extends Deadline for Three RFAs

July 9, 1999

NCI Has No Intention Of “Dismembering” Groups, Official Says

June 12, 1998

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

May 30, 2014

Alliteration And Prayer Were Andrew von Eschenbach’s Tools For Making Progress Possible For People.

May 19, 2006

Cancer Death Rates Improving, But Still Higher, In Blacks

February 23, 2007

Clinical Trials Approved In August 2002 By NCI

September 27, 2002